Literature DB >> 6827150

Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin.

C W Norden, M Shaffer.   

Abstract

Vancomycin was used alone and in combination with rifampin in the treatment of experimental osteomyelitis due to Staphylococcus aureus in rabbits. Treatment with 60 mg of vancomycin/kg of body weight twice a day for 28 days was ineffective in sterilizing infected rabbit bones. Rifampin (40 mg/kg) injected once a day for 28 days sterilized 57% of infected rabbit bones. Treatment with a combination of vancomycin and rifampin for either 14 or 28 days was significantly more effective than either drug used alone, sterilizing 84% and 90%, respectively, of the infected bones of treated animals. A possible explanation for the failure of vancomycin when used alone may be that its in vitro activity against the infecting strain of S. aureus (as measured by minimal inhibitory concentrations or minimal bactericidal concentrations) was substantially less under anaerobic conditions (that is, at partial pressures of oxygen analogous to those in osteomyelitic bones) than under aerobic conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6827150     DOI: 10.1093/infdis/147.2.352

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.

Authors:  Samuel A Shelburne; Daniel M Musher; Kristina Hulten; Heather Ceasar; Michael Y Lu; Imran Bhaila; Richard J Hamill
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 2.  In vivo antibiotic synergism: contribution of animal models.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  Antimicrobial therapy for bone and joint infections.

Authors:  Saima Aslam; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

4.  Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin.

Authors:  Q N Luu; T B Buxton; D R Nelson; J P Rissing
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

5.  The management gram-negative bacterial haematogenous vertebral osteomyelitis: a case series of diagnosis, treatment and therapeutic outcomes.

Authors:  Simon Matthew Graham; Adelle Fishlock; Peter Millner; Jonathan Sandoe
Journal:  Eur Spine J       Date:  2013-04-01       Impact factor: 3.134

6.  Concentrations of vancomycin in bone and serum of normal rabbits and those with osteomyelitis.

Authors:  K J Wilson; J T Mader
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

7.  Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.

Authors:  M Drancourt; A Stein; J N Argenson; A Zannier; G Curvale; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 8.  Cefepime clinical pharmacokinetics.

Authors:  M P Okamoto; R K Nakahiro; A Chin; A Bedikian
Journal:  Clin Pharmacokinet       Date:  1993-08       Impact factor: 6.447

9.  Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.

Authors:  T O'Reilly; S Kunz; E Sande; O Zak; M A Sande; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  [Knee joint infections].

Authors:  S Oestern; D Varoga; R Trompetter; S Lippross; T Klüter; M Weuster; O Schröder; A Seekamp
Journal:  Unfallchirurg       Date:  2013-03       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.